Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3863 Survival and prognostic factors in appendiceal neuroendocrine tumors (ANET) and goblet cell carcinoma (aGCC)

Introduction: Appendiceal goblet cell carcinomas (aGCC) present with overlapping features of appendiceal neuroendocrine neoplasms (ANET) and adenocarcinomas. A previous study found that ANET with peritoneal metastases have a 5-year survival rate of 7%. Recent studies show that ANET rarely metastasizes, contrary to aGCC. The latest WHO classification excluded aGCC from the group of NETs and classified it as appendiceal adenocarcinomas.

Conference:

Presenting Author: Dijke K

Authors: Dijke K, Levy S, van den Berg J, Tesselaar M,

Keywords: Goblet cell carcinoma, Appendiceal neuroendocrine tumor, Survival,

#3173 Intestinal obstruction (IO) in patients receiving peptide receptor radionuclide therapy (PRRT) for gastro-enteropancreatic neuroendocrine tumors (GEP-NETs): Potential predictors and association with overall survival (OS)

Introduction: There are concerns for the risk of IO in patients with GEPNETs, especially in cases with peritoneal metastases or mesenteric vascular encasement.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Badawy M

Authors: Badawy M, Hobday T, Johnson G, Halfdanarson T, Young J,

Keywords: gastrointestinal NETs, PRRT (Lu-DOTATATE), intestinal obstruction, overall survival,

#3163 Comparison of whole-body MRI and 68Ga-DOTATATE PET-CT findings in patients with suspected peritoneal metastases from neuroendocrine tumors

Introduction:

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Engbersen M

Authors: Engbersen M, Versleijen M, Lambregts D, Beets-Tan R, Tesselaar M,

Keywords: 68Ga-DOTATATE PET/CT, MRI, PET/CT, diffusion-weighted MRI, metastatic NET,

#1282 Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Frequency, Treatment and Prognosis

Introduction: Data on peritoneal metastases (PM) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are scarce.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Madani A

Authors: Madani A, Thomassen I, Van Gestel Y, Van Der Bilt J, Haak H,

Keywords: peritoneal metastases, peritoneal carcinomatosis, gastroenteropancreatic neuroendocrine tumors, GEP-NETs, prognosis ,

#707 Neuroendocrine Carcinoma: Surgery of Peritoneal Metastasis

Introduction: Neuroendocrine tumor (NET)-derived peritoneal metastases (PM) are not really described nor taken into account in the literature, yet they exert an impact on overall survival (OS)

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Dumont F

Authors: Elias D, David A, Sourouille I, Honoré C, Goéré D,

Keywords: neuroendocrine tumor, peritoneal metastases, hyperthermic intraperitoneal chemotherapy,